- •Dedication
- •Dedication
- •Preface
- •Contents
- •Contributors
- •Travel Awards
- •About the Editors
- •1.1 Introduction
- •1.2 Methods
- •1.2.1 RNA Preparation and cDNA Labeling
- •1.2.2 Hybridization of Slides, Image Acquisition and Bioinformatics
- •1.2.3 Real-Time PCR
- •1.3.2 Microarray Analysis of Bouse C Model
- •1.3.3 Microarray Analysis of MOT1 Mouse
- •1.4 Discussion
- •References
- •2 Regulation of Angiogenesis by Macrophages
- •2.1 Macrophage Polarization and Its Role in Angiogenesis
- •References
- •3.1 Introduction
- •3.2 Materials and Methods
- •3.2.1 Reagents
- •3.2.2 Animals and Retina Explant Culture
- •3.2.3 Cell Culture
- •3.2.4 Western Blot Assay
- •3.3 Results
- •3.3.1 Phorbol Esters Increase Rod Generation
- •3.3.2 Expression of PKC Isoforms in Developing Retina
- •3.3.3 Activation of PKC Decreases Phosphorylation of STAT3
- •References
- •4.1 Introduction
- •4.3 In Silico Information
- •4.4 Expression and Distribution in the Retina
- •4.5 Transmembrane Topology
- •4.6 Binding to PEDF Ligands
- •4.7 Phospholipase Activity
- •4.8 PEDF-R Activity in Retinal Cells
- •4.9 Conclusions
- •References
- •References
- •6 The Association Between Telomere Length and Sensitivity to Apoptosis of HUVEC
- •6.1 Introduction
- •6.2 Methods
- •6.2.1 The Culture of HUVEC and the Construction of Cell Division Model
- •6.2.2 Construction of an Apoptosis Model of HUVEC with Free Hydroxyl Radicals
- •6.2.3 Measurement of Apoptosis Rates and Telomere Lengths
- •6.2.4 Statistics Analysis
- •6.3 Results
- •6.3.1 Relationship Between the Time of Culture and the Telomere Length
- •6.3.2 Relationship Among Apoptosis Rates, Culture Times and Oxidation
- •6.3.3 Oxidation Enhances the Telomere Shortening
- •6.4 Discussion
- •References
- •7.1 Regulation of cGMP Levels in Photoreceptor Outer Segments
- •7.2 Retinal Disorders Associated with Mutations in RetGCs and PDE6
- •7.3 Analysis of Teleost RetGC and PDEs in Retinal Function and Disorders
- •References
- •8 RDS in Cones Does Not Interact with the Beta Subunit of the Cyclic Nucleotide Gated Channel
- •References
- •9.1 Introduction
- •9.2 Material and Methods
- •9.2.1 Animals
- •9.2.2 Methods
- •9.2.3 Statistical Analysis
- •9.3 Results
- •9.4 Discussion
- •References
- •10.1 Introduction
- •10.2 Methods and Results
- •10.2.1 ZBED4 mRNA is Expressed in Human Retina
- •10.2.2 ZBED4 mRNA is Expressed in Mouse and Human Cones
- •10.2.3 ZBED4 is Expressed Both in Nuclei and Cytoplasm of Human Cones
- •10.2.3.1 Human ZBED4 is Also Expressed in Müller Cells Endfeet
- •10.2.4 Human ZBED4 is Distributed Between Nuclear and Cytoplasmic Retinal Fractions
- •10.2.5 Subcellular Localization of ZBED4 in Stably Transfected Cells
- •10.3 Discussion
- •References
- •11 Tubby-Like Protein 1 (Tulp1) Is Required for Normal Photoreceptor Synaptic Development
- •11.1 Introduction
- •11.2 Methods
- •11.2.1 Animals
- •11.3 Results
- •11.4 Discussion
- •References
- •12.1 Introduction
- •12.2 Experimental Procedures
- •12.2.1 Animal
- •12.2.2 Immunohistochemistry
- •12.2.3 RT-PCR Analysis
- •12.2.4 Behavioral Analysis
- •12.3 Results
- •12.4 Discussion
- •12.4.2 GAP43 Is a Good Marker for Monitoring the Long Process of Optic Nerve Regeneration in Fish
- •References
- •13 Multiprotein Complexes of Retinitis Pigmentosa GTPase Regulator (RPGR), a Ciliary Protein Mutated in X-Linked Retinitis Pigmentosa (XLRP)
- •13.1 X-Linked RP (XLRP)
- •13.2 Retinitis Pigmentosa GTPase Regulator (RPGR)
- •13.3 RPGR Isoforms in the Retina
- •13.4 Animal Models of RPGR
- •13.5 Sensory Cilia
- •13.6 Retinal Degeneration Caused by Mutations in Ciliary Proteins
- •13.9 Conclusion
- •References
- •14 Misfolded Proteins and Retinal Dystrophies
- •14.1 Endoplasmic Reticulum Stress and Retinal Degeneration
- •14.2 Misfolded Proteins in Photoreceptors
- •14.3 Misfolded Proteins in Retinal Pigment Epithelial Cells
- •14.4 Pharmacologic Targeting of Protein Misfolding to Prevent Retinal Degeneration
- •References
- •15.1 Introduction
- •15.6 Perspective
- •References
- •16.1 Introduction
- •16.2 RCS Rat and MerTK Receptor: An Intimate Story
- •16.3 Changes Associated with Absence of MerTK in the Rat Retina
- •16.4 Daily Rhythmic Activation of Mertk: The Intracellular Way
- •16.5 The Debate About MerTK Ligands In Vivo
- •16.6 Perspectives
- •References
- •17.1 Introduction
- •17.3 Implications for IRBP and Cone Function
- •17.4 The Cone Visual Cycle
- •References
- •18.1 Introduction
- •18.2 Material and Methods
- •18.2.1 Reagents
- •18.2.2 Cell Culture
- •18.2.3 Flow Cytometry
- •18.3 Results
- •18.3.2 Oxidative Stress of Renal Tubular Epithelial Cells Does Not Alter Surface Expression of Crry by the Cells
- •18.4 Discussion
- •References
- •19 Role of Metalloproteases in Retinal Degeneration Induced by Violet and Blue Light
- •19.1 Introduction
- •19.2 Objective
- •19.3 Materials and Methods
- •19.4 Results
- •19.5 Conclusion
- •References
- •20.1 Summary
- •20.2 Introduction
- •20.3 Materials and Methods
- •20.3.1 Primary Human RPE Cell Culture
- •20.3.3 Mitochondrial Morphometrics
- •20.3.4 Protein and Weight Estimation of RPE Cells and Mitochondria
- •20.3.7 Expression of Mitochondrial Associated Genes
- •20.4 Results
- •20.4.1 Age Related Sensitivity of RPE Cells to Oxidative Stress
- •20.4.2 Variation in Mitochondrial Number, Structure, and Size
- •20.4.5 Expression of Genes Associated with Mitochondrial Function
- •20.5 Discussion
- •References
- •21 Ciliary Transport of Opsin
- •21.1 Introduction
- •21.2 Methods
- •21.3 Results
- •21.4 Discussion
- •References
- •22 Effect of Hesperidin on Expression of Inducible Nitric Oxide Synthase in Cultured Rabbit Retinal Pigment Epithelial Cells
- •22.1 Introduction
- •22.2 Materials and Methods
- •22.2.1 Preparing Hesperidin Extract of Pericarpium Citri Reticulatae
- •22.2.3 Cell Culture
- •22.2.4 MTT Cell Viability Assay
- •22.2.5 Assay of NO Production
- •22.2.6 Cellular Immunohistochemistry of iNOS
- •22.2.7 Statistical Analysis
- •22.3 Results
- •22.3.2 RPE Cells Morphology
- •22.3.4 Assay of NO and iNOS
- •22.4 Discussion
- •References
- •23.1 Introduction
- •23.2 Materials and Methods
- •23.2.1 Rabbit Retina Tissues
- •23.2.2 RNA Extraction
- •23.2.3 miRNA Microarray Analysis
- •23.2.4 Data Analysis
- •23.2.5 Bioinformatics Analysis of the Selected Mirnas
- •23.3 Results and Discussion
- •23.3.1 miRNA Microarray Analysis
- •23.3.2 Putative miRNA Target Gene Prediction
- •References
- •24.1 Introduction
- •24.2 Materials and Methods
- •24.2.1 Experiment with Animals
- •24.2.2 -Galactosidase Assay
- •24.3 Results
- •24.3.1 Generation of Transgenic Mice
- •24.3.2 Localization of Cre Function in Transgenic Mice
- •24.4 Discussion
- •References
- •25.1 Introduction
- •25.2 Methods
- •25.3 Result
- •25.4 Conclusions
- •References
- •26.1 PSC Proteins Involved in Inherited Retinal Degenerations
- •26.2 Structure of Photoreceptor Sensory Cilium Complex
- •26.3 Protein Components of Photoreceptor Sensory Cilium: PSC Proteome
- •26.4 Novel Photoreceptor Cilia Proteins in PSC Proteome
- •26.4.1 Subcellular Locations of Candidate Novel PSC Proteins
- •26.4.2 Functional Analysis of Novel PSC Proteins in Photoreceptor and Renal Cilia
- •26.4.2.1 shRNAs Against Novel PSC Genes
- •26.4.2.2 Evaluation of Phenotypes of shRNA Knockdown in mIMCD3 Cells and PSCs
- •26.5 TTC21B Protein in Photoreceptor Sensory Cilia and Renal Primary Cilia
- •26.5.1 TTC21B Localizes to the Basal Bodies and Transition Zone of Primary and Photoreceptor Sensory Cilia
- •26.5.2 TTC21B is Required for Primary Cilia and Photoreceptor Sensory Cilia Formation
- •26.6 Future Direction: Screening Novel PSC Genes for Mutations that Cause IRDs
- •References
- •27.1 Introduction
- •27.2 Materials and Methods
- •27.2.1 RNA Interference
- •27.2.2 Construction of Mouse Anti Elovl4 Gene shRNA
- •27.2.3 Tissue Culture
- •27.2.4 Fatty Acid Analysis
- •27.3 Results
- •27.3.1 661W Cells Express Elovl4 and Can Elongate 18:3n3 and 22:5n3 to Longer Chain Fatty Acids
- •27.4 Discussion
- •References
- •28 Molecular Pathogenesis of Achromatopsia Associated with Mutations in the Cone Cyclic Nucleotide-Gated Channel CNGA3 Subunit
- •28.1 Introduction
- •28.2 Materials and Methods
- •28.2.1 Constructs, Cell Culture and Transfection
- •28.2.3 Electrophysiological Recordings
- •28.2.4 SDS-PAGE and Western Blot Analysis
- •28.3 Results
- •28.3.1 The R218C and R224W Mutations Cause Loss of Channel Function
- •28.4 Discussion
- •References
- •29.1 Introduction
- •29.2 Materials and Methods
- •29.2.1 Patients and Ophthalmologic Examinations
- •29.2.2 Molecular Genetic Analysis
- •29.3 Results and Discussion
- •29.3.1 adRP
- •29.3.2 Bothnia Dystrophy
- •29.4 Conclusions
- •References
- •30.1 Introduction
- •30.2 Properties of Rhodopsin CSNB Mutants
- •30.2.1 Spectral and Photochemical Properties
- •30.2.2 Retinal Binding Kinetics of Rhodopsin CSNB Mutants
- •30.2.3 Activity of CSNB Mutants
- •30.2.3.1 In Vitro Assays of CSNB Mutants
- •30.2.3.2 Electrophysiological Studies on Transgenic Animal Models
- •30.3 Proposed Mechanisms of CSNB Mutations
- •30.3.1 Desensitization Due to Mutant Opsin Activity in Xenopus
- •30.3.2 Proposed Dark-Active Rhodopsin in Mouse
- •30.4 Future Studies
- •References
- •31 GCAP1 Mutations Associated with Autosomal Dominant Cone Dystrophy
- •31.2 Guanylate Cyclase 1 (GC1) and GCAP1
- •31.3 The EF Hand Motifs of GCAP1
- •31.5 EF3: The GCAP1(Y99C) and GCAP1(N104K) Mutations
- •31.6 EF4: The GCAP1(I143NT), GCAP1(L151F) and GCAP1(E155G) Mutations
- •31.7 Conclusion
- •References
- •32.1 Introduction
- •32.2 Methodology
- •32.2.1 Molecular Genetic Studies
- •32.2.2 Electrophysiological Studies
- •32.3 Results
- •32.3.1 RS1 Mutations in Western Australian Families
- •32.3.3.1 Family Information
- •32.3.3.2 Patient Information
- •32.3.3.3 Genetic Information
- •32.4 Discussion
- •References
- •33.1 Introduction
- •33.2 Materials and Methods
- •33.2.1 Subjects
- •33.2.2 DNA Extraction
- •33.2.4 RFLP Analysis
- •33.2.5 Statistical Analysis
- •33.3 Results
- •33.4 Discussion
- •References
- •34.1 Introduction
- •34.2 Materials and Methods
- •34.2.1 Animal Experiments and Experimental Groups
- •34.2.2 Web-Based siRNA Design Protocols Targeting Claudin-5
- •34.2.4 Indirect Immunostaining of Retinal Flatmounts
- •34.2.5 Assessment of BRB Integrity by Perfusion of Hoechst (H33342)
- •34.2.6 Magnetic Resonance Imaging (MRI)
- •34.3 Results
- •34.3.1 Claudin-5 Levels in Retinal Flatmounts
- •34.3.3 MRI Analysis of Ibrb Integrity Following Rnai of Claudin-5
- •34.4 Discussion
- •References
- •35 Spectral Domain Optical Coherence Tomography and Adaptive Optics: Imaging Photoreceptor Layer Morphology to Interpret Preclinical Phenotypes
- •35.1 Introduction
- •35.2 Materials and Methods
- •35.2.1 Subjects
- •35.2.2 Adaptive Optics Retinal Imaging
- •35.2.3 Spectral Domain Optical Coherence Tomography
- •35.3 Results
- •35.3.1 Cone Photoreceptor Mosaic Topography
- •35.3.2 Outer Nuclear Layer Thickness
- •35.4 Discussion
- •References
- •36.1 Introduction
- •36.2 Pharmacological Strategies for Misfolding Mutant Rod Opsin
- •36.2.1 Pharmacological Chaperones
- •36.2.2 Kosmotropes
- •36.2.3 Molecular Chaperone Inducers
- •36.2.4 Autophagy Inducers
- •36.3 Conclusion
- •References
- •37 Targeted High-Throughput DNA Sequencing for Gene Discovery in Retinitis Pigmentosa
- •37.1 Introduction
- •37.2 Methods
- •37.2.1 Selection of Families
- •37.2.2 VisionCHIP Gene Selection
- •37.2.3 VisionCHIP Validation
- •37.2.4 Evaluating Potentially Pathogenic Variants
- •37.3 Conclusion
- •References
- •38 Advances in Imaging of Stargardt Disease
- •38.1 Introduction
- •38.4 Adaptive Optics Scanning Laser Ophthalmoscope
- •38.5 Conclusion
- •References
- •39.1 Materials and Methods
- •39.1.1 Cell Culture
- •39.1.3 VEGF Expression was Determined by ELISA
- •39.1.4 Statistical Analysis
- •39.2 Results
- •39.2.1 The Maximum Inhibition of VEGF Expression by Protamine Sulfate
- •39.2.2 Protamine Sulfate Inhibits the RF/6A Cell VEGF Expression at the Hypoxic Condition
- •39.2.3 Protamine Sulfate Inhibits the Binding of VEGF to Its Receptor
- •39.3 Discussions
- •39.3.1 The Inhibition Effect of Protamine Sulfate on VEGF
- •39.3.2 Inhibition of the Binding Between VEGF and Its Receptor
- •39.3.3 The Potential Use of Protamine Sulfate Inhibition of Angiogenic Eye Diseases
- •References
- •40.1 Introduction
- •40.2 Methods
- •40.2.1 Immunohistochemial Staining of Choroidal Endothelia
- •40.2.2 Analysis of Choriodal Density with Photoshop 8.0
- •40.3 Results and Discussion
- •40.3.1 Analysis Of Choroidal Density
- •40.3.2 Usefulness of the Methodology
- •40.3.3 Summary
- •References
- •41 Thioredoxins 1 and 2 Protect Retinal Ganglion Cells from Pharmacologically Induced Oxidative Stress, Optic Nerve Transection and Ocular Hypertension
- •41.1 Introduction
- •41.2 Methods
- •41.2.1 Animals
- •41.2.2 RGC Counting
- •41.2.3 RGC Isolation
- •41.2.4 Western Blot Analysis
- •41.2.5 RGC-5 Culture and Transfection
- •41.2.6 Cell Viability Assay
- •41.2.7 In Vivo Electroporation (ELP)
- •41.2.8 Statistical Analysis
- •41.3 Results
- •41.3.1.1 TRX Expression in RGC-5 Cells in Response to Oxidative Stress
- •41.3.1.2 The Levels of TRX Proteins After ONT
- •41.3.1.3 The Levels of TRX Proteins After IOP Elevation
- •41.3.2 The Effect of TRX1 and TRX2 Overexpression on RGC Survival
- •41.3.2.2 TRX1 and TRX2 Overexpression Increases RGC Survival After ONT
- •41.3.2.3 TRX1 and TRX2 Overexpression Increases RGC Survival After IOP Elevation
- •41.4 Discussion
- •References
- •42 Near-Infrared Light Protect the Photoreceptor from Light-Induced Damage in Rats
- •42.1 Introduction
- •42.2 Material and Methods
- •42.2.1 Animal
- •42.2.2 Light Damage
- •42.2.3 670 nm LED Treatment
- •42.2.4 Evaluation of Photoreceptor Cell Function by Electroretinography
- •42.2.5 Morphological Evaluation of Photoreceptor Rescue by Quantitative Histology
- •42.2.6 Statistical Analysis
- •42.3 Results
- •42.3.1 LED Attenuated the Light Damage Area in Retinas
- •42.3.2 LED Protected the Morphology of Light Damage Retina
- •42.3.3 LED Protected the Function of Light Damage Retina
- •References
- •43.1 Introduction
- •43.2 Methods
- •43.2.1 Animals
- •43.2.2 Cell Preparation and Subretinal Transplantation
- •43.2.3 Flash-Electroretinogram (F-ERG) Recordings
- •43.2.5 Data Analysis
- •43.3 Results
- •43.3.1 ERG Amplitudes and Latencies
- •43.3.2 ONL Thickness
- •43.3.3 Graft Cells Survival After Subretinal Transplantation
- •43.4 Discussion
- •References
- •44.1 Introduction
- •44.2 Mechanisms of ATP Release and Degradation
- •44.2.1 ATP Release
- •44.2.2 Degradation of ATP
- •44.3 Purinergic Signaling in the Retina
- •44.3.1 Purinergic Modulation of Neuronal Signaling
- •44.3.2 ATP and Glial Transmission
- •44.4 The Role of Purinergic Receptors in Retinal Disease
- •44.5 Concluding Remarks
- •References
- •45.1 Background
- •45.3 FAF Findings in Early AMD with Drusen Only
- •45.4 FAF Findings in Late AMD with Geographic Atrophy
- •45.5 Progression of Geographic Atrophy
- •45.6 Mechanisms of Progression
- •45.7 Research to Prevent Progression
- •45.8 Discussion
- •References
- •46 Endoplasmic Reticulum Stress as a Primary Pathogenic Mechanism Leading to Age-Related Macular Degeneration
- •46.1 Age Related Macular Degeneration Is a Leading Cause of Vision Loss
- •46.3 ER Stress and Oxidative Stress Interact
- •46.5 Future Experimental Approaches
- •References
- •47 Proteomic and Genomic Biomarkers for Age-Related Macular Degeneration
- •47.1 Introduction
- •47.2 Methods
- •47.3 Results
- •47.3.1 CEP Adducts and Autoantibodies Are Elevated in AMD Plasma
- •47.3.2 AMD Risk Based on CEP Biomarkers and Genotype
- •47.3.3 The Association Between CEP Biomarkers and AMD Risk Genotypes
- •47.4 Discussion
- •References
- •48.1 Introduction
- •48.2 Methods
- •48.2.1 Chemicals
- •48.2.2 Establishment and Maintenance of hRPE Cell Cultures
- •48.2.3 Cellular Proliferation
- •48.2.4 Immunoprecipitation Assay
- •48.2.5 Statistical Analysis
- •48.3 Results
- •48.3.1 Effect of Glucose on 14C-CTGF Synthesis in hRPE Cells
- •48.3.2 Effect of IGF-1 on 14C-CTGF Synthesis in hRPE cells
- •48.4 Discussion
- •References
- •49.1 Introduction
- •49.1.3 Peroxisome Proliferator Activated Receptors (PPARs) are Expressed in ARPE19 Cells
- •49.2 LcPUFA Regulates Gene Expression in ARPE19 Cells
- •49.2.1 Purpose and Methods
- •49.2.2 Results
- •49.2.3 Discussion
- •References
- •50.1 Introduction
- •50.2 Cigarette Smoking as a Risk Factor for AMD
- •50.2.1 AMD and Cigarette Smoke
- •50.2.2 Cigarette Smoke Constituents
- •50.3 Oxidative Stress
- •50.3.1 Oxidative Damage in AMD
- •50.3.2 Reactive Oxygen Species in Cigarette Smoke
- •50.3.3 Acrolein-Induced Oxidative Stress
- •50.3.4 Cadmium-Induced Oxidative Stress
- •50.4 Cigarette Smoke Depletion of Antioxidant Protection
- •50.4.1 Systemic Antioxidant Mechanisms
- •50.4.2 Local Ocular Antioxidants
- •50.5 Non-oxidative Chemical Damage by Cigarette Smoke
- •50.5.1 Nicotine
- •50.5.2 Polycyclic Aromatic Hydrocarbons
- •50.6.2 Cigarette Smoke and Complement Pathway
- •50.7 Vascular Changes
- •50.8 Conclusions
- •References
- •51.1 Oxidative Stress and Age-Related Macular Degeneration
- •51.2 The Ubiquitin Proteolytic System (UPS) and Oxidative Stress in the Retina
- •51.3 The UPS and the Cytoprotective Transcription Factor, Nrf2
- •References
- •52 Slit-Robo Signaling in Ocular Angiogenesis
- •52.1 Ocular Angiogenesis
- •52.2 Slit-Robo Signaling in Axon Guidance
- •52.3 Slit-Robo Signaling in Angiogenesis
- •52.4 Slit-Robo Signaling in Ocular Angiogenesis
- •52.5 Signaling Pathway of Slit-Robo System in Angiogenesis
- •52.6 Perspective
- •References
- •53.1 Introduction
- •53.2 Materials and Methods
- •53.2.1 Animals and Biosafety
- •53.2.2 MNU-Induced Retinal Degeneration
- •53.2.3 Electroretinography
- •53.2.4 Histological Examination and Immunohistochemistry
- •53.3 Results
- •53.3.1 Fundus Examination and Histology of the Retina
- •53.3.3 BrdU Incorporation
- •53.3.4 Immunohistology of Nestin
- •References
- •54 Differences in Photoreceptor Sensitivity to Oxygen Stress Between Long Evans and Sprague-Dawley Rats
- •54.1 Introduction
- •54.2 Methods
- •54.2.1 Animal Strains and Oxygen Exposure
- •54.2.2 Electroretinography
- •54.2.3 Immunohistochemistry and TUNEL Labeling
- •54.3 Results
- •54.3.1 Rod and Cone Components of the ERG after Hyperoxia
- •54.3.2 Impact of Hyperoxia on the Rate of Photo receptor Death
- •54.3.3 Impact of Hyperoxia on GFAP Expression
- •54.4 Discussion
- •References
- •55.1 Introduction
- •55.2 The AY9944 Rat Model of SLOS: Biochemical Findings
- •55.3 Retinal Degeneration in the SLOS Rat Model: Histology and Ultrastructure
- •References
- •56.1 Introduction
- •56.1.1 The Pde6brd1 Mouse and Increased [cGMP]
- •56.1.2 Calcium Regulation and Overload in the Photoreceptor Inner Segment
- •56.2 D-cis-diltiazem and Neuroprotection in the Retina
- •56.2.1 Criticism of the Frasson Study
- •56.3 Other Players May Be Involved
- •References
- •57.1 Introduction
- •57.2 Materials and Methods
- •57.2.1 Animals and Reagents
- •57.2.2 Induction of Retinal I/R
- •57.2.4 Statistical Analysis
- •57.3 Results
- •57.3.1 Effect of PBNA on Serum NO Content in Retinal I/R Injury
- •57.3.2 Effect of PBNA on T-NOS Activity in Retinal I/R Injury
- •57.3.3 Effect of PBNA on iNOS Activity in Retinal I/R Injury
- •57.3.4 Effect of PBNA on Serum eNOS Activity in Retinal I/R Injury
- •57.4 Discussion
- •References
- •References
- •59.1 Introduction
- •59.2 Materials and Methods
- •59.2.1 Experimental Animals
- •59.2.3 Construction of the pur-GFP Reporter Vector
- •59.2.4 Morpholino and Microinjections
- •59.2.5 In Situ Hybridization
- •59.2.6 RNA Isolation, RT-PCR and mRNA Synthesis
- •59.3 Results
- •59.3.2 Similar Phenotypes of Purpurin and Crx Morphant
- •References
- •60.1 Introduction
- •60.2 Bipolar Cell Function in Retinal Degeneration
- •60.2.1 Glutamate Receptors of Bipolar Cells in the Normal and Degenerating Retina
- •60.2.2 Evidence for Bipolar Cell Dysfunction
- •60.2.2.1 Rod Bipolar Cells
- •60.2.2.2 Cone Bipolar Cells
- •60.3 Ganglion Cell Function in Retinal Degeneration
- •References
- •61.1 Introduction
- •61.2 Methods
- •61.2.1 Animals and Rearing
- •61.2.2 Measurement of Outer Nuclear Layer Thickness
- •61.2.3 Counting Photoreceptor Nuclei
- •61.3 Results
- •61.4 Discussion
- •References
- •62.1 Introduction
- •62.2 Retinitis Pigmentosa
- •62.4 IMPDH Structure and Function
- •62.5 IMPDH Binds Single Stranded Nucleic Acids
- •62.6 Retinal Isoforms of IMPDH1
- •62.7 Kinetic and Nucleic Acid Binding Properties of Retinal IMPDH1
- •62.8 Conclusion
- •References
- •63.1 Introduction
- •63.2 Methods
- •63.3 Results
- •63.4 Discussion
- •63.5 Conclusion
- •References
- •64.1 Introduction
- •64.2 Results
- •64.2.1 Evaluation of Optimal IMPDH1 Suppressors
- •64.2.2 RP10 Mouse Model
- •64.3 Discussion
- •References
- •65 Correlation Between Tissue Docosahexaenoic Acid Levels and Susceptibility to Light-Induced Retinal Degeneration
- •65.1 Introduction
- •65.2 Methods
- •65.3 Results
- •65.4 Discussion
- •References
- •66.1 Introduction
- •66.2 Materials and Methods
- •66.2.1 Animal
- •66.2.2 Immunohistochemical Staining
- •66.2.3 Western Blot Test
- •66.2.4 Müller Cell Cultures
- •66.2.5 Data Analysis
- •66.3 Results
- •66.3.1 Morphology and Quantity Changes of Müller Cells
- •66.3.2 Expression of GFAP and ERK in RCS Rat Müller Cells
- •66.3.3 Effect of Mixed Retinal Cells of RCS Rats on Normal Müller Cells
- •66.4 Discussion
- •References
- •67.1 Introduction
- •67.2 Materials and Methods
- •67.2.1 Animals and Reagents
- •67.2.2 Induction of RI/R
- •67.2.4 Statistical Analysis
- •67.3 Results
- •67.3.1 The Effect of DSS on the Concentration of MDA in Serum After RI/R Injury
- •67.3.2 The Effect of DSS on the Activity of SOD in Serum After RI/R Injury
- •67.3.4 The Effect of DSS on the Concentration of Serum NO After RI/R Injury
- •67.4 Discussion
- •References
- •68.1 Introduction
- •68.2 Materials and Methods
- •68.2.1 Animals
- •68.2.2 Functional Testing
- •68.2.3 In Vivo Imaging
- •68.3 Results
- •68.3.1 Function
- •68.3.2 Morphology
- •68.4 Discussion
- •References
- •69.1 Introduction
- •69.2 Materials and Methods
- •69.2.1 Mice and Light Exposure
- •69.3 Results
- •69.3.3 Jak3 mRNA Is Induced Similarly in the Model of Light Induced Photoreceptor Cell Death and the rd1 Mouse Model
- •69.4 Discussion
- •References
- •70.1 Introduction
- •70.2 Diseases Associated with RDS Mutations
- •70.3 Current Animal Models
- •70.4 Gene Therapy in rds Models
- •70.5 Viral Gene Therapy Approaches
- •70.6 Non-viral Approaches
- •References
- •71.1 Introduction
- •71.2 Materials and Methods
- •71.2.1 Retinal Stem Cell Isolation and Culture
- •71.2.2 Single Sphere Passaging
- •71.2.3 Bromodeoxyuridine Labeling
- •71.2.4 Retinal Stem Cell Differentiation
- •71.3 Results
- •71.3.2 Retinal Neurosphere Proliferation
- •71.3.3 Differentiation of Retinal Cells Precursors from RSCs
- •71.4 Discussion
- •References
- •72 A Multi-Stage Color Model Revisited: Implications for a Gene Therapy Cure for Red-Green Colorblindness
- •72.1 Introduction
- •72.2 A Brief History of Color Vision Theory
- •72.3 Color Vision from an Evolutionary Perspective
- •References
- •73 Achromatopsia as a Potential Candidate for Gene Therapy
- •73.1 Human Achromatopsia
- •73.1.1 Clinical Manifestations
- •73.1.2 Current Achromatopsia Treatments
- •73.2 Genetics of Human Achromatopsia
- •73.2.1 GNAT2 Achromatopsia
- •73.2.2 CNG Achromatopsia
- •73.2.3 Achromatopsia Gene Therapy
- •73.3 The Mutant Gnat2 Mouse and Gene Therapy
- •73.3.1 The Cnga3 Mutant Mouse and Gene Therapy
- •73.3.2 The Cngb3 Mutant Dog and Gene Therapy
- •73.4 Prospects for Achromatopsia Gene Therapy
- •References
- •74.1 Introduction
- •74.2 Effects of CNTF/LIF on Photoreceptor and Bipolar Neuron Differentiation
- •74.3 Effects of CNTF/LIF on Muller Glia Genesis and Late Progenitor Proliferation
- •74.4 Effects of LIF Misexpression on Retinal Vasculature Development
- •74.5 Expression of CNTF/LIF Signaling Components in the Developing Retina
- •74.6 Signaling Events Triggered by CNTF/LIF During Retinogenesis
- •74.7 CNTF/LIF Regulate Numerous Genes Involved in Retinogenesis
- •74.8 Perspective
- •References
- •75.1 Introduction
- •75.4 Discussion
- •References
- •76.1 The Importance of RPE Cell Function and Integrity for Photoreceptor Survival
- •76.2 The Loss of RPE Cells in Retinal Degeneration
- •76.3 DHA and NPD1 Properties and Neuroprotection
- •References
- •77 Adeno-Associated Virus Serotype-9 Mediated Retinal Outer Plexiform Layer Transduction is Mainly Through the Photoreceptors
- •77.1 Introduction
- •77.2 AAV9-Mediated Gene Transfer in the Retina
- •77.5 Subretinal Injection of AAV9 Vector Did Not Cause Acute Retinal Damage
- •77.6 Conclusions
- •References
- •Index
Chapter 8
RDS in Cones Does Not Interact with the Beta Subunit of the Cyclic Nucleotide Gated Channel
Shannon M. Conley, Xi-Qin Ding, and Muna I. Naash
Abstract Retinal degeneration slow (RDS) is a photoreceptor specific tetraspanin membrane protein. It is expressed in the rim region of rod outer segment (OS) discs and cone OS lamellae. Mutations in RDS cause both rod and cone-dominant retinal degenerations. We have recently shown that RDS functions differently in rods vs. cones, and have used the cone-dominant nrl–/– and rod-dominant wild-type (WT) murine retinas to study these differences and help understand the mechanism of rod and cone OS biogenesis. We hypothesize that the differential role of RDS in rods vs. cones is in part related to differences in RDS binding partners. RDS has been shown to bind to the GARP portion of the β subunit of the rod-cyclic nucleotide gated (CNG) channel. This interaction has been hypothesized to play a role in anchoring the disc rim to the rod plasma membrane. In this study we show that RDS does not interact with the cone CNG. Given that cone lamellae are not entirely encased in plasma membrane and therefore may have different anchoring requirements compared with rods, this observation may help explain some of the differential behavior of RDS in rods vs. cones.
Over 70 different disease causing mutations in the photoreceptor specific protein retinal degeneration slow (RDS) have been identified. Usually, mutations in photoreceptor-specific genes cause predictable disease phenotypes, i.e. rod specific genes associate with forms of rod dominant diseases (such as retinitis pigmentosa, RP) while mutations in cone specific genes tend to cause cone-dominant diseases (such as macular degeneration, MD). In contrast, different mutations in RDS have been linked to both rod-dominant and cone-dominant disease. The spectrum of RDS-associated retinal disease phenotypes ranges from traditional RP to MD to butterfly macular dystrophy to cone-rod degeneration depending on the mutation (http://www.retina-international.com/sci-news/rdsmut.htm).
M.I. Naash (B)
Department of Cell Biology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., BMSB 781, Oklahoma, OK 73126-0901, USA
e-mail: muna-naash@ouhsc.edu
R.E. Anderson et al. (eds.), Retinal Degenerative Diseases, Advances in Experimental |
63 |
Medicine and Biology 664, DOI 10.1007/978-1-4419-1399-9_8,
C Springer Science+Business Media, LLC 2010
64 |
S.M. Conley et al. |
The naturally occurring retinal degeneration slow (rds–/–) mutant mouse has proved an excellent model for studying the phenotypic divergence in RDSassociated retinal degenerations. These mice do not form OSs and exhibit slow, progressive death of photoreceptors coupled with panretinal degeneration (Chaitin et al. 1988; Sanyal et al. 1980; Sanyal and Zeilmaker 1984). In the rds+/– mouse, OSs form but do not assemble into properly organized, stacked discs (Hawkins et al. 1985; Sanyal et al. 1986). This haploinsufficiency phenotype is characterized by an early onset slow rod degeneration followed by late onset slow cone degeneration (Cheng et al. 1997). The deformed discs are capable of subnormal levels of phototransduction, but the lack of a proper OS causes degeneration throughout the retina.
Unfortunately, the wild-type (WT) mouse retina is 95–97% rods rendering it difficult to study the mechanisms underlying cone degeneration associated with mutations in RDS. Even in cone only models such as the early ages of the rhodopsin knockout mouse (rho–/–), the small number of cones makes analysis very difficult. The recent development of a cone-dominant mouse model containing a null mutation in the Neural Retinal Leucine Zipper (NRL) transcription factor gene (Daniele et al. 2005; Mears et al. 2001; Nikonov et al. 2005) has provided an elegant way to overcome the rod-bias problem. When retinal progenitor cells fail to receive the NRL regulatory cue, they divert from a developmental fate to rods and form blueresponsive cones instead (Farjo et al. 1997; Farjo et al. 1993; Mitton et al. 2000; Rehemtulla et al. 1996; Swaroop et al. 1992). The nrl–/– mouse is an ideal model for studying MD since it makes possible the examination of cones in the absence
of rods. We have recently taken advantage of the nrl–/– mouse to study the behavior of RDS in cones. Unlike the WT rods, cones of the nrl–/– retina lacking RDS
(nrl–/–/rds–/–) retain OS structures and the capacity for photopic visual function. The cone OSs of the nrl–/–/rds–/– are severely malformed and have no lamellae, but
continue to express OS proteins such as S-opsin. This situation is in marked contrast to the WT and underscores the different role of RDS in rods and cones.
The question remains though, what causes RDS to behave differently in rods vs. cones? Expression of RDS is limited to the OS rim region of both rod and cone photoreceptor disc rims/lamellae (Arikawa et al. 1992; Moritz et al. 2002). RDS forms tetramers in the photoreceptor inner segment which then traffic to the OS and further assemble via the second intracellular (D2) loop disulfide bonds into octamers and other higher order complexes. RDS is known to form non-covalent heterotetramers with its homologue, a protein called rod outer segment membrane protein 1 (ROM-1) in addition to homotetramers (Chakraborty et al. 2008; Goldberg and Molday 2000; Goldberg et al. 1995). However, differential interactions with ROM-1 are unlikely to be responsible for rod-cone differences in RDS behavior. Both rods and cones express ROM-1 and our biochemical studies on ROM-1 in the nrl–/– retina show that RDS/ROM-1 are biochemically similar in cones and rods (Chakraborty et al. 2008).
Little is known though about other potential RDS interacting partners in rods and cones. Tetraspanin proteins typically assemble with themselves and other proteins
8 RDS in Cones Does Not Interact with the Beta Subunit |
65 |
into a large functional protein complex known as the tetraspanin web which is similar to but distinct from lipid rafts (Hemler 2003; Levy and Shoham 2005; Stipp et al. 2003). This web consists of proteins that are covalently and non-covalently bound (similar to RDS and ROM-1) and of proteins that are more loosely associated. The function of tetraspanins is often dictated or modulated by the composition of this tetraspanin web, so it makes sense that differential behavior of RDS in rods vs. cones might result from different interacting partners in the two cell types.
In addition to ROM-1, RDS in the rod dominant retina is known to interact with at least two other proteins. The first protein, melanoregulin, is a protein associated with membrane fusion. Kathy Boesze Battaglia’s group has shown that in concert with melanoregulin, RDS helps mediate membrane fusion and thus possibly OS disc sealing at the base of the OS (Boesze-Battaglia 2000; Boesze-Battaglia et al. 2007). The expression of melanoregulin and its potential interactions with RDS in cones have not been studied, but represent a particularly interesting area for future experimentation.
The second known RDS interacting protein is the β subunit of the rod cyclic nucleotide-gated (CNG) channel. The CNG channel functions as a heterotetramer comprised of α and β subunits (Kaupp et al. 1989). It is responsible for the resting dark current in rod photoreceptors and closes upon hydrolysis of cGMP by phosphodiesterase after light induced G-protein coupled receptor/second messenger signaling (Kaupp et al. 1989; Pugh 2000). The N-terminus of the β subunit has a large glutamic acid/proline rich domain called GARP (Colville and Molday 1996). There are also two free protein forms of this GARP domain, GARP-1 and the slightly longer GARP-2 (Colville and Molday 1996; Korschen et al. 1999).
These proteins are intrinsically disordered and have been known to act as scaffolding type proteins in other tissues (Batra-Safferling et al. 2006). Molday’s group has shown that both free GARP and the GARP domain of the CNG channel β subunit can interact with RDS (Poetsch et al. 2001) in bovine rod OSs. They hypothesize that CNG-GARP-RDS interactions might be responsible for the anchoring filaments that have been observed between the disc rim and plasma membrane of rods (Poetsch et al. 2001; Roof and Heuser 1982). They further hypothesize that interactions between free GARP and RDS might serve to connect adjacent discs. Although there is no direct proof supporting this hypothesis, advanced structural analysis of GARP has shown that its size and shape are consistent with this role (Batra-Safferling et al. 2006).
Cones also have a cGMP gated channel responsible for maintenance of the dark, “off” current, but it is not the same channel as that expressed in rods. It is thought that differences in the regulation/kinetics of the cone vs. rod CNG channels help explain the differences in phototransduction kinetics between the two cell types. Cone channels have a ten-fold lower ligand sensitivity than rod channels and are between 30 and 100 times less sensitive to light (Picones and Korenbrot 1995; Pugh 2000). It has recently been shown that the cone channel also functions as a heterotetramers composed of α and β subunits (Matveev et al. 2008). The β subunit of the cone channel does not have a GARP domain, so we hypothesized that RDS would
66 |
S.M. Conley et al. |
not interact with the cone channel thus partially explaining the differential role of RDS in rods vs. cones.
Our first step was to determine expression of the cone CNG channel in WT and nrl–/– retina using polyclonal antibodies against the cone CNG channel subunit CNGA3 and CNGB3 (Matveev et al. 2008). Immunohistochemical analysis of retinal sections taken from 1-month-old animals labeled with the CNGA3 and
CNGB3 antibodies demonstrates that both subunits of the cone CNG channel are expressed in the cone OSs of WT and nrl–/– retinas (Fig. 8.1a). We do not detect any
protein expression in other retinal cell types, or in other portions of the photoreceptor. The labeling pattern in the WT retina is consistent with cone-only expression, but to confirm this, co-labeling studies were undertaken with rod opsin (mAB 1D4, generously shared by Dr. Robert Molday) and CNGA3. The left panel of Fig. 8.1b shows CNGA3 labeling while the middle panel is rhodopsin (1D4) labeling. The labeling patterns are quite distinct and the two proteins do not co-localize (overlay, right) indicating that cone CNG is not expressed in rods. To confirm the size of the
Fig. 8.1 CNGA3 and CNGB3 is expressed in cones OSs of WT and nrl–/– Retinas; (a) Paraffin embedded sections from P30 WT or nrl–/– mice were stained with CNGA3 and CNGB3 polyclonal antibodies and visualized using anti-rabbit Cy3 secondary antibody. Sections were counterstained with DAPI to label nuclei. Expression of cone channel subunits is limited to the OS layer in both WT and nrl–/– retina. Scale bar 20 μm. (b) P30 WT paraffin embedded sections were stained with CNGA3 (left) and mAB 1D4 (against rhodopsin-middle). The two proteins do not co-localize (right) indicating that cone CNG is not expressed in rods. Scale bar 10 μm. OS, outer segment; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer
8 RDS in Cones Does Not Interact with the Beta Subunit |
67 |
cone CNG subunits, whole retinal extracts from P30 retinas underwent reducing and non-reducing SDS-PAGE/Western blotting. Rod-dominant WT extracts were used as controls while nrl–/– was used as a cone-dominant model. Historically, the only available cone-dominant model has been the young rhodopsin knockout (rho–/–) retina, so those retinas were also included as a control, although they express significantly lower quantities of cone proteins than the nrl–/– retina. Under reducing conditions, both the α and β subunits of cone CNG appear as monomers of approximately 75 kDa (Fig. 8.2a, b left) in all samples. This is consistent with the predicted peptide sizes of 72 kDa (A) and 79 kDa (B) and is in contrast to rod CNG channel subunits which have been shown to migrate abnormally on SDS-PAGE (Poetsch et al. 2001). The involvement of disulfide-linkages in multi-subunit channel assembly was examined by non-reducing SDS-PAGE. A significant amount of CNGB3 dimer was detected at ~170 kDa (Fig. 8.2b, right) although little dimerization of CNGA3 was noticed in these retinas (Fig. 8.2a, right).
Fig. 8.2 CNGB3 is present as both a monomer and dimer, while CNGA3 is present only as a monomer; Retinal extracts from P30 WT (rod-dominant), nrl–/– and rho–/– (cone-dominant) mice underwent reducing (left) and non-reducing (right) SDS-PAGE and Western blotting. (a) CNGA3 is only present as the monomeric form (~75 kDa) while CNGB3 (b) exhibits a substantial quantity of both monomer and dimer
Since previous studies had shown that the bovine rod CNG channel associates with RDS (Poetsch et al. 2001) via the GARP portion of the CNG β-subunit, we wanted to confirm that we could detect this interaction in mice. Retinal extracts from one month old WT mice underwent immunoprecipitation (IP) with either the RDS antibody or the GARP monoclonal antibody 4B1 (generously shared by Dr. Robert Molday, University of British Columbia). Bovine rod OSs were used as a positive control while nrl–/– retinal extracts served as a negative control since they do not express the rod CNG-GARP. As shown in Fig. 8.3a (input), WT retinal extracts express both splice variants of free GARP while the rodless nrl–/– retinas do not. As demonstrated by reciprocal co-IP shown in the left two panels of Fig. 8.3a, in mouse rods, RDS does interact with GARP. To determine whether the cone CNG β-subunit
68 |
S.M. Conley et al. |
Fig. 8.3 The rod CNG β subunit interacts with RDS while the cone CNG β subunit does not; (a) Retinal extracts from WT and nrl–/– P30 mice and bovine OSs underwent IP using either RDS C-terminal antibody or monoclonal (4B1) GARP antibody. This reciprocal co-IP confirms that rod CNG does interact with RDS. (b) WT and nrl–/– retinal extracts and nrl–/– OSs underwent IP with RDS C-terminal antibody. Although CNGB3 was present in the samples, none was detected in the immunoprecipitants
interacts with RDS, similar experiments were undertaken. RDS complexes from WT and nrl–/– retinal extracts or nrl–/– OS preparations were immunoprecipitated using the RDS antibody. OS preparations (Chakraborty et al. 2008) were used as an enriched source of OS proteins such as CNG and RDS. The IP was successful as evidenced by detection of RDS in all three samples (Fig. 8.3b, bottom). However the β subunit of cone CNG was not detected in any of the immunoprecipitants although it was detected in the initial samples (Fig. 8.3b, top left).
These results confirm our hypothesis that the cone CNG β-subunit does not interact with RDS, most likely due to the lack of a GARP domain in the cone channel. Furthermore, they clearly identify the first difference in the RDS tetraspanin web in rods vs. cones. It is likely that additional study will identify further RDS interacting partners that are rod or cone specific and will further enhance our understanding of the role of RDS in OS biogenesis.
Acknowledgment The monoclonal antibodies for this study (4B1 and 1D4) were generously shared with us by Dr. Robert Molday, University of British Columbia. This study was supported by grants from the National Institutes of Health (EY10609 & EY018656), Core Grant for Vision Research EY12190, and the Foundation Fighting Blindness. Dr. Naash is the recipient of a Research to Prevent Blindness James S. Adams Scholar Award.
